Precision BioSciences Sues Lonza for Patent Infringement | GenomeWeb

NEW YORK (GenomeWeb News) – Precision BioSciences said today that it is suing Lonza Group and a number of its affiliates for patent infringement.

The lawsuit, filed in the US District Court for the District of Delaware, alleges that Switzerland-based Lonza's import and sale of its GS Xceed Gene Expression System and CHOK1SV knock-out cell line in the US infringes US Patent No. 8,377,674, which applies to Precision Bio's Directed Nuclease Editor genome editing technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genetic method to gauge age of ancient samples, genetic polymorphisms in mouse strain, and more.

Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

After nine years, the Canadian government is loosening its restrictions on government scientists' ability to speak to the press and public.